In another study, using a linear peptide epitope of epidermal growth factor receptors (EGFR) as the imprinting template, epitope‐imprinted nanoMIP was prepared through a solid‐phase imprinting strategy.[9b] The nanoMIP exhibited high affinity, with a Kd of 7.7 nM for binding with the peptide and a Kd of 3.6 nM for binding with the extracellular domain of EGFR protein.[9b] Consequently, the nanoMIP was capable of selectively recognizing tumor cells overexpressing EGFR, which was demonstrated by flow cytometric analysis and confocal fluorescence imaging (Figure 2 B). This evidence concerns the gene EGFR and neoplasm.